دورية أكاديمية
أعرض في EDS

Understanding migraine in Saudi society: An assessment of public knowledge and attitudes: A cross-sectional study.

التفاصيل البيبلوغرافية
العنوان: Understanding migraine in Saudi society: An assessment of public knowledge and attitudes: A cross-sectional study.
المؤلفون: Alshehri FS; Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia., Ashour AM; Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia., Alharbi AS; Pharmacy Practice Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia., Hakami AY; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Alorfi NM; Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
المصدر: PloS one [PLoS One] 2024 Jun 21; Vol. 19 (6), pp. e0304840. Date of Electronic Publication: 2024 Jun 21 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Migraine Disorders*/epidemiology , Health Knowledge, Attitudes, Practice*, Humans ; Male ; Saudi Arabia/epidemiology ; Adult ; Female ; Cross-Sectional Studies ; Middle Aged ; Adolescent ; Young Adult ; Surveys and Questionnaires
مستخلص: Objective: This study aims to assess the knowledge and perceptions of the public toward migraine in Saudi Arabia.
Methods: This cross-sectional survey assessed the knowledge and perceptions of migraine among Saudi Arabian individuals. The study was conducted over three months in 2023 (1st of June 2023 to 31st of August 2023) using a prevalidated online questionnaire divided into four sections.
Results: A total of 1,975 adults aged between 18 and 64 completed the web-based survey. Of these, over half were male (n = 1,268; 64.2%). The main causes of migraine identified by the participants were genetic disease (n = 540, 27.3%), followed by physical disease (n = 341, 17.3%), head trauma (n = 274, 13.9%), and psychiatric disease (n = 157, 7.9%). The main symptoms identified by the participants were photophobia (21%), followed by inability to control urine (14.1%), vomiting and nausea (13.8%), and vision loss (8.3%). The majority of the participants in this study had a good knowledge of migraines, while 49% had poor knowledge. The migraine knowledge score was significantly associated with the participants' gender (p = 0.002), age (p = 0.0001), educational level (p = 0.001), employment status (p = 0.001), monthly income (p = 0.0001), region (p = 0.0001), and history of migraine (p = 0.0001).
Conclusion: Although one-third of the participants exhibiting good knowledge, deficiencies existed in certain clinical aspects, emphasizing the need for targeted educational interventions to enhance public awareness and understanding of migraines.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Alshehri et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
References: Hematology. 2022 Dec;27(1):412-419. (PMID: 35413216)
J Headache Pain. 2020 Dec 2;21(1):137. (PMID: 33267788)
Headache. 2021 Jan;61(1):60-68. (PMID: 33349955)
Mayo Clin Proc. 2018 Nov;93(11):1648-1653. (PMID: 30392545)
Braz J Phys Ther. 2020 Jul - Aug;24(4):306-317. (PMID: 31813696)
Cephalalgia. 2021 Oct;41(11-12):1240-1248. (PMID: 33990148)
Front Public Health. 2022 Mar 21;10:723229. (PMID: 35387181)
Health Rep. 2014 Jun;25(6):10-6. (PMID: 24941316)
J Headache Pain. 2020 Feb 7;21(1):11. (PMID: 32033539)
Medicina (Kaunas). 2022 May 22;58(5):. (PMID: 35630103)
Headache. 2022 Jan;62(1):4-10. (PMID: 35041220)
Eur J Neurol. 2022 Jan;29(1):350-357. (PMID: 34519136)
J Family Community Med. 2020 Jan-Apr;27(1):37-45. (PMID: 32030077)
Neurol Sci. 2020 Dec;41(Suppl 2):429-436. (PMID: 32845494)
Headache. 2019 Sep;59(8):1286-1299. (PMID: 31407321)
Saudi Med J. 2021 Oct;42(10):1103-1108. (PMID: 34611005)
Expert Opin Ther Targets. 2020 Feb;24(2):91-100. (PMID: 32003253)
Headache. 2006 Oct;46(9):1334-43. (PMID: 17040331)
Am J Manag Care. 2019 Jan;25(2 Suppl):S23-S34. (PMID: 30681821)
Pharmacol Res. 2020 Jan;151:104587. (PMID: 31809852)
Front Neurol. 2021 Feb 02;11:618375. (PMID: 33603708)
J Neurol. 2023 Jul;270(7):3567-3573. (PMID: 37043031)
BMJ. 2018 Jan 31;360:k96. (PMID: 29386181)
Front Public Health. 2022 Aug 15;10:912424. (PMID: 36052013)
Headache. 2022 Oct;62(9):1093-1104. (PMID: 36226379)
Biomed Res Int. 2022 Jan 18;2022:8690562. (PMID: 35087910)
Drug Dev Res. 2021 Nov;82(7):896-906. (PMID: 33792938)
J Headache Pain. 2019 Aug 30;20(1):92. (PMID: 31470791)
Front Neurol. 2022 Feb 23;12:800605. (PMID: 35281991)
J Clin Med Res. 2018 Feb;10(2):125-133. (PMID: 29317957)
J Family Med Prim Care. 2020 May 31;9(5):2324-2331. (PMID: 32754496)
Neurol Ther. 2020 Dec;9(2):375-394. (PMID: 33001385)
Dan Med J. 2021 Oct 2;68(11):. (PMID: 34983726)
Expert Rev Neurother. 2020 Mar;20(3):207-225. (PMID: 31933391)
N Engl J Med. 2019 Dec 5;381(23):2230-2241. (PMID: 31800988)
Cephalalgia. 1988;8 Suppl 7:1-96. (PMID: 3048700)
Curr Neurol Neurosci Rep. 2022 Jun;22(6):327-334. (PMID: 35482279)
Front Public Health. 2021 Dec 09;9:785568. (PMID: 34957036)
Front Neurol. 2022 Mar 18;13:719467. (PMID: 35370920)
ScientificWorldJournal. 2020 Jun 16;2020:4790254. (PMID: 32607079)
Prim Care Companion CNS Disord. 2021 Sep 30;23(5):. (PMID: 34592795)
Eur J Neurol. 2012 May;19(5):703-11. (PMID: 22136117)
Front Neurol. 2020 Oct 26;11:569405. (PMID: 33193010)
Clin Pract. 2023 Apr 23;13(3):553-568. (PMID: 37218802)
JAMA. 2022 Jan 4;327(1):93. (PMID: 34982118)
تواريخ الأحداث: Date Created: 20240621 Date Completed: 20240621 Latest Revision: 20240623
رمز التحديث: 20240623
مُعرف محوري في PubMed: PMC11192400
DOI: 10.1371/journal.pone.0304840
PMID: 38905175
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0304840